0,868  0,008  Antiinflammatory
0,747  0,005  Cardiovascular analeptic
0,752  0,023  Apoptosis agonist
0,681  0,006  Antipsoriatic
0,677  0,005  UDP-glucuronosyltransferase substrate
0,665  0,019  Teratogen
0,649  0,008  Nitric oxide antagonist
0,668  0,028  Caspase 9 stimulant
0,644  0,012  Sensitization
0,640  0,019  Embryotoxic
0,630  0,022  Cyclophilin D inhibitor
0,630  0,022  Antidiabetic
0,606  0,012  Immunosuppressant
0,620  0,027  CYP3A4 substrate
0,585  0,004  Antiacne
0,589  0,012  Hepatic disorders treatment
0,568  0,004  Contraceptive
0,578  0,016  CYP2C19 substrate
0,560  0,014  AR expression inhibitor
0,562  0,017  Antineoplastic (melanoma)
0,578  0,034  Transcription factor NF kappa B inhibitor
0,566  0,041  Antineoplastic (breast cancer)
0,547  0,028  CYP2C9 substrate
0,539  0,022  Antipruritic, allergic
0,547  0,037  Analgesic
0,511  0,010  Antineoplastic (endocrine cancer)
0,518  0,019  Antifungal
0,499  0,005  Interleukin 6 antagonist
0,486  0,004  Lipocortins synthesis antagonist
0,518  0,042  TNF expression inhibitor
0,492  0,020  Chemopreventive
0,485  0,024  CTGF expression inhibitor
0,481  0,022  NOS3 expression inhibitor
0,456  0,008  Abortion inducer
0,449  0,009  Prostatic (benign) hyperplasia treatment
0,479  0,039  Antineoplastic (colorectal cancer)
0,475  0,037  Antineoplastic (colon cancer)
0,442  0,005  Insulin secretagoues
0,461  0,027  Antineoplastic (cervical cancer)
0,432  0,005  Antiviral (Influenza A)
0,436  0,010  Anesthetic
0,434  0,012  UGT1A4 substrate
0,453  0,034  Antineoplastic (ovarian cancer)
0,437  0,022  UGT2B4 substrate
0,461  0,048  Antileukemic
0,421  0,008  Antiviral (Influenza)
0,409  0,009  Antipruritic, non-allergic
0,451  0,056  Antibacterial
0,395  0,012  UGT2B7 substrate
0,413  0,035  ICAM1 expression inhibitor
0,388  0,012  Prostate disorders treatment
0,375  0,004  ABCA1 expression enhancer
0,380  0,013  Melanin inhibitor
0,392  0,027  Antihypoxic
0,375  0,013  Hair growth stimulant
0,410  0,049  Prostate cancer treatment
0,391  0,035  Cytostatic
0,393  0,038  Metabolic disease treatment
0,399  0,044  Antihypercholesterolemic
0,379  0,024  Sodium/bile acid cotransporter inhibitor
0,399  0,045  Respiratory analeptic
0,399  0,047  Aldehyde oxidase inhibitor
0,396  0,046  FMO1 substrate
0,389  0,040  Antiepileptic
0,377  0,034  Calcium channel activator
0,377  0,038  Chemoprotective
0,352  0,014  Interferon gamma antagonist
0,374  0,039  Cytotoxic
0,399  0,065  Antineoplastic (lung cancer)
0,372  0,046  Lipoprotein disorders treatment
0,335  0,011  Neurotrophic factor enhancer
0,360  0,040  NOS2 expression inhibitor
0,377  0,059  Inflammatory Bowel disease treatment
0,359  0,044  Antioxidant
0,323  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,325  0,015  Protein-tyrosine phosphatase inhibitor
0,346  0,036  Hypolipemic
0,314  0,005  Contraceptive female
0,363  0,061  Bone diseases treatment
0,305  0,007  Androgen antagonist
0,304  0,009  Antineoplastic antibiotic
0,342  0,054  Analeptic
0,324  0,042  Antineoplastic (liver cancer)
0,282  0,002  Retinoic acid beta receptor agonist
0,287  0,007  Contraceptive male
0,334  0,056  Antineoplastic (pancreatic cancer)
0,310  0,033  Antiparkinsonian, rigidity relieving
0,318  0,042  Carcinogenic
0,306  0,031  UGT1A1 substrate
0,341  0,068  Cholesterol antagonist
0,288  0,019  UGT2B15 substrate
0,275  0,007  Estrogen antagonist
0,266  0,002  Retinoic acid receptor agonist
0,328  0,067  CYP2D6 substrate
0,310  0,049  Flavin-containing monooxygenase substrate
0,310  0,049  Proliferative diseases treatment
0,252  0,004  Adenylate cyclase stimulant
0,258  0,018  UGT2B9 substrate
0,269  0,032  Pneumotoxic
0,239  0,002  Retinoid X beta receptor agonist
0,294  0,059  Antineoplastic (non-small cell lung cancer)
0,271  0,038  Hepatoprotectant
0,242  0,014  Endometrios treatment
0,239  0,016  Autism spectrum disorders treatment
0,231  0,011  Arachidonic acid antagonist
0,272  0,052  Antiparasitic
0,290  0,071  Antiosteoporotic
0,231  0,014  Antirickettsial
0,212  0,003  Retinoic acid alpha receptor agonist
0,270  0,063  5 Hydroxytryptamine uptake stimulant
0,283  0,076  CYP1A2 substrate
0,280  0,077  FMO3 substrate
0,214  0,012  Antiinfertility, female
0,267  0,065  Vascular (periferal) disease treatment
0,273  0,071  UGT1A9 substrate
0,209  0,014  Growth stimulant
0,217  0,023  Antihyperlipoproteinemic
0,226  0,033  Protein kinase stimulant
0,223  0,030  Toxic, respiratory center
0,198  0,005  Androgen agonist
0,262  0,069  Tumour necrosis factor alpha release inhibitor
0,199  0,006  SULT1E1 substrate
0,207  0,017  SULT1A1 substrate
0,195  0,008  Estrogen agonist
0,245  0,058  Antihypertriglyceridemic
0,191  0,005  Cushing's syndrome treatment
0,210  0,024  Cholesterol synthesis inhibitor
0,190  0,005  Anabolic
0,265  0,081  Antidiabetic (type 2)
0,263  0,081  GST M1-1 substrate
0,180  0,002  Retinoic acid gamma receptor agonist
0,243  0,065  UGT1A6 substrate
0,194  0,018  Choleretic
0,185  0,010  Keratolytic
0,227  0,053  Sleep disorders treatment
0,175  0,002  Retinoic acid beta receptor antagonist
0,338  0,165  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,193  0,022  Expectorant
0,183  0,012  Actinic keratosis treatment
0,171  0,002  Retinoid X gamma receptor agonist
0,169  0,002  Retinoic acid receptor gamma antagonist
0,188  0,023  Microtubule formation inhibitor
0,200  0,037  UGT2B10 substrate
0,168  0,009  UGT2B11 substrate
0,193  0,034  Antifungal enhancer
0,161  0,002  Retinoic acid alpha receptor antagonist
0,250  0,092  Radioprotector
0,185  0,027  Movement disorders treatment
0,159  0,002  Retinoic acid receptor antagonist
0,169  0,013  Estrogen receptor beta antagonist
0,279  0,122  GST A substrate
0,162  0,011  Postmenopausal disorders treatment
0,212  0,062  Antihelmintic
0,215  0,067  Anesthetic general
0,165  0,018  Ca2+-transporting ATPase inhibitor
0,158  0,014  Inducible nitric-oxide synthase inhibitor
0,228  0,085  DNA synthesis inhibitor
0,149  0,007  Estrogen receptor beta agonist
0,227  0,085  Antineoplastic (glioma)
0,212  0,075  VCAM1 expression inhibitor
0,139  0,004  RNA-directed RNA polymerase stimulant
0,238  0,104  Cardioprotectant
0,198  0,065  P-glycoprotein inhibitor
0,189  0,057  UGT1A3 substrate
0,200  0,068  Mutagenic
0,152  0,020  CC chemokine 6 receptor antagonist
0,231  0,099  5 Hydroxytryptamine release stimulant
0,170  0,039  DNA polymerase I inhibitor
0,247  0,116  Mood disorders treatment
0,159  0,028  Mucolytic
0,156  0,026  Sulfotransferase substrate
0,159  0,031  GABA receptor agonist
0,297  0,169  5 Hydroxytryptamine release inhibitor
0,178  0,051  Antiparkinsonian, tremor relieving
0,140  0,014  Aromatase inhibitor
0,206  0,082  Antineoplastic (glioblastoma multiforme)
0,169  0,045  Neurotrophic factor
0,146  0,023  Antispirochetal
0,185  0,062  Succinate dehydrogenase inhibitor
0,152  0,032  Alcohol dehydrogenase substrate
0,248  0,129  Apoptosis antagonist
0,135  0,016  Ornithine decarboxylase inhibitor
0,164  0,049  Carcinogenic, group 3
0,159  0,045  Antieczematic
0,176  0,064  Antimutagenic
0,150  0,040  Coagulant
0,156  0,046  Farnesoid X receptor antagonist
0,115  0,007  Estrogen receptor alpha agonist
0,112  0,005  SULT2A1 substrate
0,138  0,031  Antineoplastic alkaloid
0,121  0,015  Premenstrual syndrome treatment
0,156  0,050  Cocaine dependence treatment
0,221  0,117  Gastrin inhibitor
0,235  0,133  Antineoplastic (osteosarcoma)
0,153  0,052  Skin whitener
0,106  0,005  Postcoital contraceptive
0,136  0,036  Antineoplastic, alkylator
0,117  0,018  Na+ K+ transporting ATPase inhibitor
0,107  0,008  Progesterone antagonist
0,157  0,060  Antidiabetic (type 1)
0,103  0,007  Heme oxygenase stimulant
0,170  0,074  Antipruritic
0,185  0,089  Insulin sensitizer
0,144  0,049  Antitussive
0,126  0,031  Posttraumatic stress disorder treatment
0,105  0,011  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,197  0,104  RNA-directed DNA polymerase inhibitor
0,232  0,140  Interleukin 2 agonist
0,148  0,057  Pregnane X receptor agonist
0,151  0,064  SULT1A3 substrate
0,167  0,081  Phobic disorders treatment
0,144  0,058  Alpha-N-acetylglucosaminidase inhibitor
0,152  0,067  Genotoxic
0,133  0,048  Glutathione S-transferase substrate
0,092  0,008  Lipocortins synthesis agonist
0,127  0,043  AMP-activated protein kinase stimulant
0,121  0,039  GST T1-1 substrate
0,144  0,063  Psychosexual dysfunction treatment
0,087  0,006  Glucocorticoid antagonist
0,099  0,018  Anticholelithogenic
0,110  0,030  Tocolytic
0,169  0,089  Antiviral (Hepatitis)
0,125  0,045  Nav1.1 sodium channel blocker
0,106  0,027  Glycine receptor antagonist
0,109  0,031  GABA A receptor agonist
0,166  0,090  LDLR expression enhancer
0,082  0,005  Pregnane X receptor antagonist
0,127  0,053  Interleukin 8 antagonist
0,156  0,081  Antiviral (Hepatitis C)
0,099  0,028  CDC25A inhibitor
0,120  0,050  Neutropenia treatment
0,081  0,011  Aldosterone antagonist
0,110  0,039  Potassium channel activator
0,159  0,090  Tumour necrosis factor antagonist
0,103  0,036  Transcription factor NF kappa B stimulant
0,141  0,075  Lipid peroxidase inhibitor
0,072  0,006  GABA uptake inhibitor
0,096  0,030  Estrogen receptor alpha antagonist
0,102  0,037  Antiviral (Trachoma)
0,099  0,035  Antibiotic
0,123  0,059  Menstruation disorders treatment
0,069  0,006  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,125  0,063  Adenylate cyclase inhibitor
0,090  0,028  Glycine receptor agonist
0,078  0,017  Sphingosine kinase 2 inhibitor
0,199  0,138  Tyrosine 3 hydroxylase inhibitor
0,144  0,084  Eye irritation, high
0,087  0,028  Antitreponemal
0,077  0,018  Sphingosine kinase inhibitor
0,182  0,124  Peptidyltransferase inhibitor
0,060  0,002  Retinoid X gamma receptor antagonist
0,079  0,021  Hypercalcemia treatment
0,070  0,012  Adenylate cyclase 1 inhibitor
0,101  0,044  Antidote, mercury
0,065  0,008  Hypogonadism treatment
0,075  0,019  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,060  0,004  Progesterone agonist
0,070  0,014  Anesthetic inhalation
0,062  0,008  Alpha 1L adrenoreceptor agonist
0,127  0,073  Vanilloid 1 agonist
0,139  0,086  Diuretic
0,077  0,024  Andropause treatment
0,144  0,092  Growth hormone agonist
0,068  0,016  Estradiol 17 beta-dehydrogenase inhibitor
0,090  0,040  Ankylosing spondylitis treatment
0,126  0,076  Antihemorrhagic
0,092  0,043  Antiprotozoal activity enhancer
0,160  0,111  Interleukin antagonist
0,182  0,134  Antihypotensive
0,097  0,052  Paget's disease treatment
0,051  0,008  Vanilloid 3 antagonist
0,106  0,063  HDL-cholesterol increasing
0,114  0,072  Anesthetic local
0,056  0,015  Retinoid X receptor agonist
0,114  0,073  Antineoplastic antimetabolite
0,094  0,054  Glutamate release inhibitor
0,103  0,064  GABA C receptor agonist
0,103  0,065  Carcinogenic, group 2B
0,119  0,081  Retinoprotector
0,195  0,157  Hypoxia-inducible factor 1 alpha inhibitor
0,040  0,004  Hedgehog signaling activator
0,139  0,104  Liver fibrosis treatment
0,068  0,034  Antimycoplasmal
0,124  0,090  Nav1.6 sodium channel blocker
0,047  0,014  Glucose-6-phosphate dehydrogenase inhibitor
0,081  0,047  Antidote, organophosphates
0,046  0,014  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,156  0,123  CYP2B6 inhibitor
0,159  0,128  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,079  0,049  Narcotic antagonist
0,048  0,019  Sphingosine kinase 1 inhibitor
0,145  0,117  Phospholipase C inhibitor
0,172  0,144  Hypoglycemic
0,036  0,009  Estrone sulfatase inhibitor
0,082  0,055  Opioid kappa receptor antagonist
0,043  0,017  Retinoid X alpha receptor agonist
0,077  0,051  SULT1A2 substrate
0,099  0,073  Skin irritative effect
0,094  0,070  Nitric-oxide synthase inhibitor
0,028  0,005  Progesterone receptor B antagonist
0,029  0,007  Corticosteroid-like
0,043  0,022  5-Alpha-reductase inhibitor
0,049  0,029  Microtubule stabilization
0,038  0,018  Tubulin agonist
0,041  0,022  Retinoid X receptor antagonist
0,025  0,007  Retinoid X beta receptor antagonist
0,162  0,145  Immunostimulant
0,096  0,078  UGT2B1 substrate
0,022  0,005  Telomerase stimulant
0,158  0,141  Antiviral (HIV)
0,024  0,007  Glucocorticoid agonist
0,053  0,037  Protein 50S ribosomal subunit inhibitor
0,036  0,020  Retinoid X alpha receptor antagonist
0,026  0,010  Vitamin D receptor antagonist
0,160  0,144  Antineoplastic (renal cancer)
0,060  0,045  Transcription factor AP-1 inhibitor
0,107  0,093  Cyclooxygenase 3 inhibitor
0,029  0,018  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,013  0,005  Progesterone receptor A antagonist
0,031  0,023  ATP citrate lysase inhibitor
0,095  0,087  DOPA decarboxylase inhibitor
0,083  0,076  Prolactin inhibitor
0,078  0,072  Opioid antagonist
0,043  0,038  Parathyroid hormone antagonist
0,016  0,011  Vitamin D receptor agonist
0,098  0,093  Photosensitizer
0,044  0,040  Mineralocorticoid receptor antagonist
0,068  0,064  Analgesic, opioid
0,031  0,027  Carboxypeptidase B inhibitor
0,176  0,172  Antineoplastic (sarcoma)
0,018  0,015  Antibiotic Anthracycline-like
0,007  0,004  Transcortin receptor antagonist
0,078  0,075  Estrogen-related receptor beta agonist
0,034  0,032  Farnesoid X receptor agonist
0,084  0,082  Lanosterol 14 alpha demethylase inhibitor
0,092  0,091  GABA C receptor antagonist
0,024  0,023  Nicotinic acid receptor 2 antagonist
0,020  0,020  GRP78 expression inhibitor

